James Niedel insider trades: Versartis (VSAR) stock buys and sales

10% Owner, Versartis Last trade Sep 29, 2014 27 Form 4 filings

Sold, last 12 months

0 sales

Bought, last 12 months

0 buys

Open-market trades

since 2005

Companies

last trade 2014

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where James reports to the SEC

VSARVersartis

10% Owner · last filing Oct 1, 2014

-$251K

+$1.3M

CMRXChimerix

Director · last filing Jun 29, 2017

-$41.4M

CNCEConcert Pharmaceuticals

10% Owner · last filing Feb 21, 2014

No market trades

MEIPMEI Pharma

10% Owner · last filing Nov 25, 2013

-$10.3M

RLYPRelypsa

Insider · last filing Nov 20, 2013

+$2.0M

DRTXDurata Therapeutics

10% Owner · last filing Jul 26, 2012

+$7.1M

and 4 more companies

Open-market buys and sales

19 trades reported on SEC Form 4, newest first

Date	Stock	Type	Shares	Price	Value	Holding	Reported
Sep 29, 2014	VSARVersartis	↓ Sell	12,556	$20.02	$251K	Direct	Oct 1, 2014 (2d)
Sep 11, 2014	CMRXChimerix	↓ Sell	1,099,949	$29.39	$32.3M	Indirect	Sep 11, 2014 (0d)
Mar 27, 2014	VSARVersartis	↑ Buy	60,000	$21.02	$1.3M	Direct	Mar 28, 2014 (1d)
Nov 21, 2013	MEIPMEI Pharma	↓ Sell	365,000	$8.25	$3.0M	Direct	Nov 25, 2013 (4d)
Nov 20, 2013	RLYPRelypsa	↑ Buy	185,978	$11.00	$2.0M	Indirect	Nov 20, 2013 (0d)
Oct 23, 2013	CMRXChimerix	↓ Sell	585,602	$15.51	$9.1M	Indirect	Oct 23, 2013 (0d)
May 8, 2013	MEIPMEI Pharma	↓ Sell	200,000	$8.57	$1.7M	Direct	May 8, 2013 (0d)
Apr 19, 2013	MEIPMEI Pharma	↓ Sell	257,300	$8.48	$2.2M	Direct	Apr 22, 2013 (3d)
Feb 19, 2013	MEIPMEI Pharma	↓ Sell	497,225	$6.72	$3.3M	Direct	Feb 20, 2013 (1d)
Jul 24, 2012	DRTXDurata Therapeutics	↑ Buy	784,313	$9.00	$7.1M	Indirect	Jul 26, 2012 (2d)
Jul 19, 2011	TSPTTranscept Pharmaceuticals	↓ Sell	245,062	$4.47	$1.1M	Direct	Jul 20, 2011 (1d)
Jul 14, 2011	TSPTTranscept Pharmaceuticals	↓ Sell	209,953	$4.98	$1.0M	Direct	Jul 15, 2011 (1d)
Oct 19, 2010	WHRTWorld Heart	↑ Buy	2,341,920	$2.13	$5.0M	Direct	Oct 21, 2010 (2d)
Jan 26, 2010	WHRTWorld Heart	↑ Buy	388,350	$5.15	$2.0M	Direct	Jan 28, 2010 (2d)
Jul 6, 2005	RNAISirna Therapeutics	↑ Buy	2,895,406	$1.60	$4.6M	By Sprout Capital IX L.P.	Jul 8, 2005 (2d)
Jul 6, 2005	RNAISirna Therapeutics	↑ Buy	133,712	$1.60	$214K	By Sprout IX Plan Investors, L.P.	Jul 8, 2005 (2d)
Jul 6, 2005	RNAISirna Therapeutics	↑ Buy	78,126	$1.60	$125K	Direct	Jul 8, 2005 (2d)
Jul 6, 2005	RNAISirna Therapeutics	↑ Buy	11,411	$1.60	$18K	By Sprout Entrepreneurs Fund, L.P.	Jul 8, 2005 (2d)
Jul 6, 2005	RNAISirna Therapeutics	↑ Buy	6,346	$1.60	$10K	By DLJ Capital Corporation	Jul 8, 2005 (2d)

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About James Niedel's insider trades

James Niedel is a 10% owner of Versartis (VSAR). Since Jul 6, 2005, James has reported 10 open-market purchases worth $22.4M and 9 sales worth $54.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (6 filings), conversions (5 filings), other transactions (5 filings), option exercises (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VSAR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.